Skip to main content
. 2021 Jan 11;27(2):101–109. doi: 10.1016/j.eprac.2021.01.001

Table 1.

Characteristics and Study Outcomes of Patients Divided into FT3 Tertiles

Variable FT3 tertiles
P value
2.4-4.0 pmol/L n =20 4.1-4.8 pmol/L n =17 4.9-7.4 pmol/L n = 17
Age, mean (SD) 68.75 (15.60) 56.71 (14.88) 48.98 (22.48) .006
Gender (%)
 Male 15 (75.0) 13 (76.5) 9 (52.9) .247
 Female 5 (25.0) 4 (23.5) 8 (47.1)
BMI, mean (SD) 26.49 (3.75) 26.21 (4.56) 26.66 (6.19) .97
Medical background
 DM (%) 11 (55.0) 4 (23.5) 3 (17.6) .033
 HTN (%) 10 (50.0) 8 (47.1) 3 (17.6) .093
 CVA (%) 3 (15.0) 3 (17.6) 2 (11.8) .89
 IHD (%) 4 (20.0) 1 (5.9) 0 (0.0) .095
 CHF (%) 2 (10.0) 1 (5.9) 0 (0.0) .416
 PVD (%) 0 (0.0) 1 (5.9) 0 (0.0) .33
 Autoimmune disease (%) 1 (5.0) 1 (5.9) 0 (0.0) .614
 Cognitive decline (%) 4 (20.0) 2 (11.8) 4 (23.5) .662
 Charlson index, mean (SD) 5.00 (2.79) 2.47 (1.87) 1.65 (2.34) <.001
 Smoking history (%) 3 (15.0) 3 (17.6) 0 (0.0) .205
ED clinical parameters on presentation, mean (SD)
 Oxygen room air saturation (%) 81.05 (17.92) 92.71 (5.58) 93.73 (7.03) .006
 HR (bpm) 94.75 (20.52) 78.62 (15.60) 101.30 (14.48) .009
 RR (respiration/min) 25.57 (9.06) 22.62 (11.17) 26.00 (12.17) .61
 Temperature (°C) 37.73 (0.73) 37.73 (0.92) 37.57 (0.67) .858
 SBP (mm Hg) 137.05 (21.41) 135.79 (14.99) 131.64 (22.48) .767
 DBP (mm Hg) 79.85 (10.45) 76.86 (10.01) 79.18 (10.78) .704
Laboratory results, mean (SD)
 Hb (g/dL) 12.32 (2.30) 13.88 (1.74) 12.70 (2.54) .18
 WBC (K/μL) 11.04 (7.22) 7.04 (2.76) 7.98 (2.99) .23
 PLT (K/μL) 232.10 (89.12) 228.35 (171.63) 227.47 (77.68) .55
 Neutrophils (K/μL) 9.40 (7.32) 5.21 (2.31) 5.77 (2.47) .17
 Lymphocytes (K/μL) 0.78 (0.45) 1.05 (0.59) 1.36 (0.55) .005
 Cr (mg/dL) 1.30 (0.81) 0.90 (0.33) 0.67 (0.18) .001
 Albumin (g/dL) 3.23 (0.61) 3.64 (0.65) 3.79 (0.62) .023
 ALT (IU/L) 50.35 (44.79) 32.71 (24.53) 30.71 (14.12) .13
 AST (IU/L) 79.20 (71.52) 49.06 (32.28) 42.76 (19.70) .22
 D-dimer (ng/mL) 7556.88 (15450.71) 2029.00 (2552.63) 6697.64 (18253.27) .09
 Ferritin (ng/mL) 921.99 (773.91) 647.61 (463.17) 205.33 (267.29) .002
 LDH (IU/L) 492.89 (247.49) 352.41 (154.12) 289.88 (91.94) .014
 Troponin-I HS (ng/L) 109.79 (247.62) 14.04 (15.17) 39.10 (53.19) .032
 CRP (mg/L) 154.68 (90.48) 80.70 (77.51) 31.26 (60.73) <.001
Thyroid hormones, mean (SD)
 TSH (mIU/L)a 2.51 (3.59) 2.79 (3.25) 3.12 (2.44) .2
 FT4 (pmol/L)a 13.78 (4.97) 12.54 (3.35) 13.21 (3.33) .71
 FT3 (pmol/L)a 3.40 (0.48) 4.49 (0.23) 5.56 (0.62) <.001
 Min TSH (mIU/L) 1.39 (1.88) 1.60 (2.18) 2.89 (2.47) .039
 Min FT4 (pmol/L) 9.24 (4.52) 11.14 (2.22) 12.68 (2.55) .011
 Min FT3 (pmol/L) 3.40 (0.48) 4.49 (0.23) 5.56 (0.62) <.001
Primary and secondary outcomes
 Death (n, %) 8 (40.0) 1 (5.9) 1 (5.9) .008
 Mechanical ventilation (n, %) 9 (45.0) 5 (29.4) 0 (0.0) .007
 ICU (n, %) 11 (55.0) 5 (29.4) 1 (5.9) .006
 LOS in days, mean (SD) 40.06 (43.24) 22.14 (23.55) 13.98 (11.49) .11

Abbreviations: ALT = alanine transaminase; AST = aspartate aminotransferase; BMI = body mass index; bpm = beats/min; CHF = congestive heart failure; Cr = creatinine; CRP = c-reactive protein; CVA = cerebrovascular accident; DBP = diastolic blood pressure; DM = diabetes mellitus; FT3 = free triiodothyronine; FT4 = free thyroxine; HR = heart rate; HTN= hypertension; Hb = hemoglobin; ICU = intensive care unit; IHD = ischemic heart disease; LDH = lactate dehydrogenase; LOS = length of stay; min = minimum; PLT = platelets; PVD = peripheral vascular disease; RR = respiratory rate; SBP = systolic blood pressure; TSH = thyroid stimulating hormone; WBC = white blood cell.

a

Normal reference ranges: TSH 0.4-4.0 mIU/L; FT4 7-16 pmol/L, FT3 3.3-7.2 pmol/L.